CureDuchenne Webinar – An Introduction to REGENXBIO and RGX-202

RegenXBio Webinar Post

Learn more about REGENXBIO’s new gene therapy program for the potential treatment of Duchenne. This webinar provides an overview of the company and RGX-202, a novel, advanced micro-dystrophin gene therapy for the treatment of DMD.

You’ll be prompted to enter your name and email address to view the recording.

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.